464 related articles for article (PubMed ID: 26809712)
21. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
Miller MB; Geoghegan JC; Supattapone S
PLoS Pathog; 2011 Jul; 7(7):e1002128. PubMed ID: 21779169
[TBL] [Abstract][Full Text] [Related]
22. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
23. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
24. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
25. The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons.
Radford HE; Mallucci GR
Curr Issues Mol Biol; 2010; 12(2):119-27. PubMed ID: 19767655
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
27. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
28. Protease-sensitive synthetic prions.
Colby DW; Wain R; Baskakov IV; Legname G; Palmer CG; Nguyen HO; Lemus A; Cohen FE; DeArmond SJ; Prusiner SB
PLoS Pathog; 2010 Jan; 6(1):e1000736. PubMed ID: 20107515
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin-specific protease 14 modulates degradation of cellular prion protein.
Homma T; Ishibashi D; Nakagaki T; Fuse T; Mori T; Satoh K; Atarashi R; Nishida N
Sci Rep; 2015 Jun; 5():11028. PubMed ID: 26061634
[TBL] [Abstract][Full Text] [Related]
30. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
Sakaguchi S; Uchiyama K
Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
[TBL] [Abstract][Full Text] [Related]
31. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
[TBL] [Abstract][Full Text] [Related]
32. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
33. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K].
Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162
[TBL] [Abstract][Full Text] [Related]
34. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
[TBL] [Abstract][Full Text] [Related]
35. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
[TBL] [Abstract][Full Text] [Related]
36. Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction.
Teruya K; Nishizawa K; Oguma A; Sakasegawa Y; Kitamoto T; Doh-Ura K
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):384-394. PubMed ID: 30447252
[TBL] [Abstract][Full Text] [Related]
37. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
[TBL] [Abstract][Full Text] [Related]
38. The first non-prion pathogen identified: neurotropic influenza virus.
Sakaguchi S; Hara H
Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
[TBL] [Abstract][Full Text] [Related]
39. Putting prions into focus: application of single molecule detection to the diagnosis of prion diseases.
Giese A; Bieschke J; Eigen M; Kretzschmar HA
Arch Virol Suppl; 2000; (16):161-71. PubMed ID: 11214919
[TBL] [Abstract][Full Text] [Related]
40. Prion infection of mouse neurospheres.
Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
